The digital age presents a complex challenge: protecting children online while also allowing free speech to continue to be a…
Read More →
International Emergency Economic Powers Act (50 U.S.C. 1701 et seq.) (IEEPA), the National Emergencies Act (50 U.S.C. 1601 et seq.), section 604…
Read More →
When you’ve been hurt in a motor vehicle accident or other incident caused by someone else’s irresponsible actions, you often…
Read More →
On October 28, 2025, the State of Texas filed a complaint against Johnson & Johnson and Kenvue, Inc. (“Kenvue”)—formerly the…
Read More →
Pfizer Inc. is facing a growing number of lawsuits from patients who received Depo Provera injections—including patients who received their…
Read More →
Stephen Anstey, a Government Relations & Regulatory attorney and registered federal lobbyist in our Washington, D.C. office, shares a brief…
Read More →
AI tools are now a valuable part of the day-to-day toolkit for many teams. The rewards can be great. They…
Read More →
For autologous cell and gene therapies (CGTs), the collection of patients‘ cells is the first step in the manufacture of…
Read More →
In June 2025, the US Food and Drug Administration (FDA) issued a final guidance titled Cybersecurity in Medical Devices: Quality…
Read More →
This week, the government shutdown entered its fifth week and, on Nov. 4, 2025, became the longest in history, beating…
Read More →